Content about amlodipine besylate and benazepril hydrochloride

July 25, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said.

SUPPLIER NEWS — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said. Janssen Pharmaceuticals announced the approval of Xarelto (rivaroxaban) tablets as a once-daily oral anticoagulant for DVT, a condition that could lead to pulmonary embolism.


January 4, 2011

Par Pharmaceutical has started shipping a generic version of a hypertension drug, the company said Monday.

WOODCLIFF LAKE, N.J. — Par Pharmaceutical has started shipping a generic version of a hypertension drug, the company said Monday.

Par announced the shipment of amlodipine besylate and benazepril hydrochloride capsules in the 5-mg/320-mg and 10-mg/320-mg strengths. The drug is a generic version of Novartis’ Lotrel, which has annual sales of $361 million in the two strengths, according to IMS Health.